187 related articles for article (PubMed ID: 21857739)
1. Thrombophilia and ovarian hyperstimulation syndrome: a case report.
Levy G; Lucidi RS
Hawaii Med J; 2011 May; 70(5):97-8. PubMed ID: 21857739
[TBL] [Abstract][Full Text] [Related]
2. Increased prevalence of thrombophilia among women with severe ovarian hyperstimulation syndrome.
Dulitzky M; Cohen SB; Inbal A; Seidman DS; Soriano D; Lidor A; Mashiach S; Rabinovici J
Fertil Steril; 2002 Mar; 77(3):463-7. PubMed ID: 11872195
[TBL] [Abstract][Full Text] [Related]
3. [Prevalence of thrombophilia in patients with severe ovarian hyperstimulation syndrome].
Machac S; Procházka M; Lubuský M
Ceska Gynekol; 2005 Jul; 70(4):254-7. PubMed ID: 16128122
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of inherited thrombophilia in patients with severe ovarian hyperstimulation syndrome.
Machac S; Lubusky M; Prochazka M; Streda R
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2006 Nov; 150(2):289-92. PubMed ID: 17426795
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J
Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453
[TBL] [Abstract][Full Text] [Related]
6. Unsuspected adverse effect of albumin in severe ovarian hyperstimulation syndrome: a case report.
Darii N; Pavlovic M; Doroftei B; Emil A
JBRA Assist Reprod; 2019 Oct; 23(4):430-433. PubMed ID: 31058477
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization.
Enskog A; Henriksson M; Unander M; Nilsson L; Brännström M
Fertil Steril; 1999 May; 71(5):808-14. PubMed ID: 10231037
[TBL] [Abstract][Full Text] [Related]
8. [Ovarian hyperstimulation syndrome after stimulation with highly purified hMGfor in vitro fertilization: Observational study SHOview].
Barrière P; Dewailly D; Duhamel A; Gayet V
Gynecol Obstet Fertil Senol; 2017 May; 45(5):283-290. PubMed ID: 28461237
[TBL] [Abstract][Full Text] [Related]
9. Quadruplet pregnancy complicated by ovarian hyperstimulation syndrome with spontaneous ovulation.
Sugaya S; Hiroi T
Clin Exp Obstet Gynecol; 2012; 39(3):402-4. PubMed ID: 23157058
[TBL] [Abstract][Full Text] [Related]
10. Thrombosis following ovarian hyperstimulation syndrome.
Kasum M; Danolić D; Orešković S; Ježek D; Beketić-Orešković L; Pekez M
Gynecol Endocrinol; 2014 Nov; 30(11):764-8. PubMed ID: 25014487
[TBL] [Abstract][Full Text] [Related]
11. Endocrine gland-derived vascular endothelial growth factor concentrations in follicular fluid and serum may predict ovarian hyperstimulation syndrome in women undergoing controlled ovarian hyperstimulation.
Gao MZ; Zhao XM; Sun ZG; Hong Y; Zhao LW; Zhang HQ
Fertil Steril; 2011 Feb; 95(2):673-8. PubMed ID: 21067720
[TBL] [Abstract][Full Text] [Related]
12. Rare manifestations of the ovarian hyperstimulation syndrome: a report of two cases.
Arikan G; Giuliani A; Gücer F; Auner H; Urdl W
Clin Exp Obstet Gynecol; 1997; 24(3):154-6. PubMed ID: 9478304
[TBL] [Abstract][Full Text] [Related]
13. Is oocyte maturation rate associated with triptorelin dose used for triggering final oocyte maturation in patients at high risk for severe ovarian hyperstimulation syndrome?
Lainas GT; Lainas TG; Sfontouris IA; Chatzimeletiou K; Venetis CA; Bosdou JK; Tarlatzis BC; Grimbizis GF; Kolibianakis EM
Hum Reprod; 2019 Sep; 34(9):1770-1777. PubMed ID: 31384921
[TBL] [Abstract][Full Text] [Related]
14. A New Perspective on the Risk of Hypercoagulopathy in Ovarian Hyperstimulation Syndrome Using Thromboelastography.
Zohav E; Almog B; Cohen A; Levin I; Deutsch V; Many A; Amit A; Cohen Y
Reprod Sci; 2017 Dec; 24(12):1600-1606. PubMed ID: 28299993
[TBL] [Abstract][Full Text] [Related]
15. Internal jugular vein thrombosis following ovarian hyperstimulation syndrome.
Fleming T; Sacks G; Nasser J
Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):87-90. PubMed ID: 22309366
[TBL] [Abstract][Full Text] [Related]
16. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
[TBL] [Abstract][Full Text] [Related]
17. Ovarian hyperstimulation syndrome after assisted reproductive technologies: trends, predictors, and pregnancy outcomes.
Schirmer DA; Kulkarni AD; Zhang Y; Kawwass JF; Boulet SL; Kissin DM
Fertil Steril; 2020 Sep; 114(3):567-578. PubMed ID: 32680613
[TBL] [Abstract][Full Text] [Related]
18. Severe ovarian hyperstimulation syndrome in a naturally conceived singleton pregnancy after ovulation induction: a case report.
Yang F; Hu H; He PZ; Zhang M; Qian Y; Li Y
Clin Exp Obstet Gynecol; 2017; 44(2):292-295. PubMed ID: 29746043
[TBL] [Abstract][Full Text] [Related]
19. Late-onset ovarian hyperstimulation syndrome developing during ovarian stimulation in an ectopic pregnancy: a case report.
Huang H; Takai Y; Samejima K; Narita T; Ichinose S; Itaya Y; Ono Y; Matsunaga S; Saitoh M; Baba K; Hayashi N; Seki H
J Med Case Rep; 2020 Jul; 14(1):110. PubMed ID: 32684165
[TBL] [Abstract][Full Text] [Related]
20. Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone agonist trigger.
Fatemi HM; Garcia-Velasco J
Fertil Steril; 2015 Apr; 103(4):870-3. PubMed ID: 25724740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
